KW
Kongming Wu

Elite Scholar

335
Works
24,284
Citations
82
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Kongming Wu

Also known as: K Wu, K. Wu, K.-L. WU, Kendall Wu, Kong-Ming Wu

335

Total Works

24,284

Citations

82

H-Index

176

i10-Index

Citation & Works Trend by Year
28 years active
Top Research Topics
Cancer Immunotherapy and Biomarkers (57) Cancer-related Molecular Pathways (55) Developmental Biology and Gene Regulation (39) Glioma Diagnosis and Treatment (35) Lung Cancer Treatments and Mutations (30)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Antibody–Drug Conjugates and Peptide–Drug Conjugates: Current Understandings and Future Perspectives MedComm 1
2026 Targeting the CTBP1–CETP axis overcomes ferroptosis resistance in non‐small cell lung cancer by altering lipid accumulation Clinical and Translational Medicine 0
2026 Radiotherapy Enhances the Oncolytic Efficacy of the Novel Oncolytic Herpesvirus VG161 and Amplifies Its Antitumor Immunity in Breast Cancer Advanced Science 0
2026 From M7824 to SHR-1701: lessons for dual PD-L1/TGF-β targeting Journal for ImmunoTherapy of Cancer 1
2026 Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16–CXCR6 signaling for potent antitumor response Nature Communications 22
2025 Challenges and strategies in clinical applications of CAR-T therapy for autoimmune diseases Journal of Hematology & Oncology 17
2025 Advances in the clinical application of bispecific antibodies in cancer therapy iScience 14
2025 Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities Journal of Hematology & Oncology 47
2025 Development and application of antibody-drug conjugates in gynecological cancers Science China Life Sciences 4
2025 429 A triple-targeted antibody-drug conjugate enhances antitumor immunity by integrating STING activation with TGF-β/PD-L1 blockade Regular and Young Investigator Award Abstracts 0
2025 479 Dual blockade of TGF-β and PD-L1 overcomes immune exclusion in HPV-associated cancers Regular and Young Investigator Award Abstracts 0
2025 The neuro-immune axis in cancer: from mechanisms to therapeutic opportunities Journal of Hematology & Oncology 35
2025 Breaking barriers: The cGAS‐STING pathway as a novel frontier in cancer immunotherapy 癌症：英文版 33
2025 Bispecific Antibody Targeting VEGF/TGF‐β Synergizes with Local Radiotherapy: Turning Tumors from Cold to Inflamed and Amplifying Abscopal Effects Advanced Science 18
2025 Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis Journal of Hematology & Oncology 40

Data source: OpenAlex API